Free Trial

ClearPoint Neuro (CLPT) Competitors

ClearPoint Neuro logo
$26.11 -2.85 (-9.84%)
Closing price 04:00 PM Eastern
Extended Trading
$25.76 -0.35 (-1.34%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLPT vs. INSP, EYE, PRCT, AORT, LMAT, LQDA, ENOV, CDRE, NVCR, and CNMD

Should you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include Inspire Medical Systems (INSP), National Vision (EYE), PROCEPT BioRobotics (PRCT), Artivion (AORT), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), Enovis (ENOV), Cadre (CDRE), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.

ClearPoint Neuro vs. Its Competitors

Inspire Medical Systems (NYSE:INSP) and ClearPoint Neuro (NASDAQ:CLPT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 7.0% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Inspire Medical Systems has a net margin of 6.17% compared to ClearPoint Neuro's net margin of -66.15%. Inspire Medical Systems' return on equity of 10.38% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems6.17% 10.38% 8.93%
ClearPoint Neuro -66.15%-94.44%-51.58%

Inspire Medical Systems has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.

Inspire Medical Systems currently has a consensus target price of $150.50, indicating a potential upside of 100.05%. ClearPoint Neuro has a consensus target price of $19.67, indicating a potential downside of 24.68%. Given Inspire Medical Systems' higher probable upside, equities analysts clearly believe Inspire Medical Systems is more favorable than ClearPoint Neuro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
1 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.40
ClearPoint Neuro
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Inspire Medical Systems has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$802.80M2.77$53.51M$1.7343.49
ClearPoint Neuro$31.39M23.65-$18.91M-$0.81-32.23

In the previous week, Inspire Medical Systems had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 9 mentions for Inspire Medical Systems and 7 mentions for ClearPoint Neuro. Inspire Medical Systems' average media sentiment score of 0.69 beat ClearPoint Neuro's score of 0.44 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ClearPoint Neuro
0 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspire Medical Systems beats ClearPoint Neuro on 12 of the 16 factors compared between the two stocks.

Get ClearPoint Neuro News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLPT vs. The Competition

MetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$823.26M$7.00B$6.12B$10.63B
Dividend YieldN/A1.16%5.66%4.71%
P/E Ratio-32.2318.9064.0822.83
Price / Sales23.65192.73612.79132.68
Price / CashN/A22.0238.5062.09
Price / Book28.385.1112.726.53
Net Income-$18.91M$178.04M$3.30B$275.96M
7 Day Performance-4.64%-2.10%1.05%-1.40%
1 Month Performance147.96%8.21%7.56%5.16%
1 Year Performance129.24%27.35%79.69%31.55%

ClearPoint Neuro Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLPT
ClearPoint Neuro
0.5896 of 5 stars
$26.11
-9.8%
$19.67
-24.7%
+138.7%$823.26M$31.39M-32.23110Analyst Forecast
Gap Up
INSP
Inspire Medical Systems
4.801 of 5 stars
$75.46
-2.3%
$154.43
+104.6%
-61.2%$2.28B$802.80M43.621,246Analyst Forecast
EYE
National Vision
2.2632 of 5 stars
$29.24
+2.5%
$24.73
-15.4%
+173.3%$2.26B$1.82B-162.4413,411Positive News
Analyst Forecast
PRCT
PROCEPT BioRobotics
2.8707 of 5 stars
$36.49
-0.5%
$70.00
+91.8%
-53.0%$2.04B$274.95M-23.54430Analyst Forecast
AORT
Artivion
3.2859 of 5 stars
$42.03
+2.4%
$43.13
+2.6%
+57.9%$1.94B$388.54M-100.061,600News Coverage
Analyst Forecast
LMAT
LeMaitre Vascular
3.8735 of 5 stars
$85.45
+1.5%
$97.60
+14.2%
-6.0%$1.91B$234.64M41.48490News Coverage
Positive News
Analyst Forecast
LQDA
Liquidia Technologies
3.3494 of 5 stars
$22.80
+4.6%
$32.11
+40.8%
+118.5%$1.88B$14M-13.4150Analyst Forecast
ENOV
Enovis
3.6481 of 5 stars
$30.19
+0.7%
$51.00
+68.9%
-19.2%$1.71B$2.11B-2.127,367Positive News
Analyst Forecast
CDRE
Cadre
2.5032 of 5 stars
$36.06
-0.8%
$31.50
-12.6%
-3.8%$1.48B$567.56M38.362,284News Coverage
Analyst Forecast
Analyst Revision
NVCR
NovoCure
4.0665 of 5 stars
$12.92
+0.2%
$28.79
+122.8%
-2.3%$1.44B$605.22M-8.281,488Positive News
Analyst Forecast
CNMD
CONMED
4.4739 of 5 stars
$45.64
-0.8%
$59.80
+31.0%
-27.9%$1.42B$1.31B12.933,900News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:CLPT) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners